2009
DOI: 10.1007/s00535-009-0146-3
|View full text |Cite
|
Sign up to set email alerts
|

Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons

Abstract: The development of modern endoscopic techniques, easier and greater access to healthcare, and interest in Helicobacter pylori infection and its implications have all led to a significant increase in upper endoscopies. In turn, gastroenterologists and pathologists have been recognizing an ever-increasing number of patterns of mucosal injury. Consequently, there is now an interest in a wider aspect of non-neoplastic gastric pathology, namely, non-HP (H. pylori) gastritis. In this review, we present major clinico… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0
6

Year Published

2011
2011
2024
2024

Publication Types

Select...
4
4
2

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(24 citation statements)
references
References 111 publications
0
15
0
6
Order By: Relevance
“…Previous reports suggest that non-H. pylori gastritis is primarily present in pediatric patients or others with underlying co-morbidities such as inflammatory bowel disease, autoimmune, and genetic diseases [51]. However, our studied population mainly constituted of adult patients with no known comorbidities; therefore, it may be plausible that other factors such as fungal and viral infections, excessive intake of NSAIDs or other drugs, and immunological disorders are responsible of inducing gastritis in these patients, as previously observed in other countries [52].…”
Section: Discussionmentioning
confidence: 89%
“…Previous reports suggest that non-H. pylori gastritis is primarily present in pediatric patients or others with underlying co-morbidities such as inflammatory bowel disease, autoimmune, and genetic diseases [51]. However, our studied population mainly constituted of adult patients with no known comorbidities; therefore, it may be plausible that other factors such as fungal and viral infections, excessive intake of NSAIDs or other drugs, and immunological disorders are responsible of inducing gastritis in these patients, as previously observed in other countries [52].…”
Section: Discussionmentioning
confidence: 89%
“…As a matter of fact, glandular atrophy as a result of chronic H. pylori ‐induced gastritis leads to reduced acid production and shifts in gastric pH value, which may facilitate the colonization of the gastric mucosa by other bacteria, viruses or even fungi . Further conditions leading to increased gastric pH are immunomodulated atrophic gastritis or acid suppressive therapy such as long‐term treatment with proton pump inhibitors (PPIs) . It has been hypothesized that bacterial N ‐nitrosation is increased and further contributes to carcinogenesis in the stomach .…”
Section: H Pylori and Its Pathophysiological Role In Upper Gastrointmentioning
confidence: 99%
“…Most importantly, studies with cohort design did not detect significant association between PGII and OSCC risk. In addition, cancer patients may develop gastritis due to non-steroidal anti-inflammatory drug (NSAID) use, opportunistic infections in stomach (cytomegalovirus, Epstein–Barr virus), malnutrition, anaemia, and consequent use of iron tablets (Abraham et al , 1999; Lauwers et al , 2010). Stage of tumours in most of our study population were III or IV at the time of diagnosis, and dysphagia was the presenting symptom, which led to high proportion of NSAID consumption among cases compared with controls (24.7% vs 15.8%, P =0.001).…”
Section: Discussionmentioning
confidence: 99%